DROPLET DIGITAL PCR IS A RELIABLE TOOL FOR MONITORING MINIMAL RESIDUAL DISEASE IN ACUTE PROMYELOCYTIC LEUKAEMIA

被引:0
|
作者
Brunetti, C. [1 ]
Anelli, L. [1 ]
Zagaria, A. [1 ]
Minervini, A. [1 ]
Casieri, P. [1 ]
Minervini, C. F. [1 ]
Orsini, P. [1 ]
Cumbo, C. [1 ]
Impera, L. [1 ]
Coccaro, N. [1 ]
Tota, G. [1 ]
Carluccio, P. [1 ]
Specchia, G. [1 ]
Albano, F. [1 ]
机构
[1] Univ Bari, Hematol Sect, DETO, Bari, Italy
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P053
引用
收藏
页码:71 / 71
页数:1
相关论文
共 50 条
  • [41] DROPLET DIGITAL PCR IMPROVE MINIMAL RESIDUAL DISEASE DETECTION IN >35% OF SAMPLES COMPARING TO RQ-PCR
    Andrade-Campos, M.
    Alfonso, P.
    Lopez de Frutos, L.
    Soro, G.
    Giraldo, P.
    HAEMATOLOGICA, 2016, 101 : 448 - 449
  • [42] Integral analysis of minimal residual disease and hematopoietic chimerism for relapse prediction using digital droplet PCR
    Waterhouse, Miguel
    Pfeifer, Dietmar
    Duque-Afonso, Jesus
    Duyster, Justus
    Bertz, Hartmut
    Finke, Juergen
    BONE MARROW TRANSPLANTATION, 2019, 54 : 113 - 113
  • [43] Evaluation of NPM1 Mutation Detection by Droplet Digital PCR for Minimal Residual Disease Detection
    Walder, R. Y.
    Stence, A. A.
    Sompallae, K.
    Sompallae, R.
    Guseva, N. V.
    Ma, D.
    Snow, A. N.
    Bossler, A. D.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2018, 20 (06): : 920 - 920
  • [44] Validation of QuantStudio 3D Digital PCR Assay for Monitoring Minimal Residual Disease in Acute Myeloid Leukemia
    Di, J.
    Yenwongfai, L.
    Sheng, T.
    Zhang, S.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2023, 25 (11): : S145 - S145
  • [45] PCR for monitoring of minimal residual disease in hematologic malignancy
    Matsuda, Kazuyuki
    Sugano, Mitsutoshi
    Honda, Takayuki
    CLINICA CHIMICA ACTA, 2012, 413 (1-2) : 74 - 80
  • [46] Digital PCR: A Reliable Tool for Analyzing and Monitoring Hematologic Malignancies
    Coccaro, Nicoletta
    Tota, Giuseppina
    Anelli, Luisa
    Zagaria, Antonella
    Specchia, Giorgina
    Albano, Francesco
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (09)
  • [47] Digital PCR as a New Method for Minimal Residual Disease Monitoring and Treatment Free Remission Management in Chronic Myeloid Leukemia Patients: Is It Reliable?
    Bernardi, Simona
    Malagola, Michele
    Farina, Mirko
    Polverelli, Nicola
    Re, Federica
    Russo, Domenico
    HEMATO, 2023, 4 (01): : 1 - 11
  • [48] Real-time RT-PCR quantification of PRAME gene expression for monitoring minimal residual disease in acute myeloblastic leukaemia
    Tajeddine, Nicolas
    Millard, Isabelle
    Gailly, Philippe
    Gala, Jean-Luc
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2006, 44 (05) : 548 - 555
  • [49] Monitoring minimal residual disease in acute myeloid leukaemia with NPM1 mutations by quantitative PCR: clonal evolution is a limiting factor
    Papadaki, Christina
    Dufour, Annika
    Seibl, Marlene
    Schneider, Stephanie
    Bohlander, Stefan K.
    Zellmeier, Evelyn
    Mellert, Gudrun
    Hiddemann, Wolfgang
    Spiekermann, Karsten
    BRITISH JOURNAL OF HAEMATOLOGY, 2009, 144 (04) : 517 - 523
  • [50] Monitoring minimal residual disease in peripheral blood in B-lineage acute lymphoblastic leukaemia
    Brisco, MJ
    Sykes, PJ
    Hughes, E
    Dolman, G
    Neoh, SH
    Peng, LM
    Toogood, I
    Morley, AA
    BRITISH JOURNAL OF HAEMATOLOGY, 1997, 99 (02) : 314 - 319